| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
CareSource
| Facility | $41,999.58 | $55,999.44 | $83,999.17 | |
CareSource
| Professional | $74,024.27 | $104,998.95 | $104,998.95 | |
Cigna
| Professional | $1,355.47 | $1,355.47 | $1,694.33 |
Oncology (ovarian), spheroid cell culture, poly (ADP-ribose) polymerase (PARP) inhibitors (niraparib, olaparib, rucaparib, velparib), tumor response prediction for each drug
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
CareSource
| Facility | $41,999.58 | $55,999.44 | $83,999.17 | |
CareSource
| Professional | $74,024.27 | $104,998.95 | $104,998.95 | |
Cigna
| Professional | $1,355.47 | $1,355.47 | $1,694.33 |